自然产品的干预,针对心肌梗塞后的新机制
Guangjie Tai1, Renhua Liu1, Tian Lin1
1Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
Chinese journal of natural medicines
|June 22, 2025
概括
天然产品通过向炎症,氧化应激和细胞死亡来治疗心肌梗塞 (MI) 是有前途的. 需要进一步的研究来探索它们作为传统疗法的替代品的潜力.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学 是一个学科.
- 自然产品研究 自然产品研究
背景情况:
- 心肌梗塞 (MI) 是导致死亡的主要原因,导致严重的心脏损伤.
- 目前针对心脏病发作的治疗方法有局限性和不良影响.
- 自然产品 (NPs) 对心血管疾病提供潜在的治疗益处.
研究的目的:
- 审查心肌梗塞的病理生理机制.
- 总结一下天然产品对心脏的有益影响.
- 探索自然产品在MI中的作用的新机制和目标.
主要方法:
- 关于心肌梗塞病理生理学的综合文献综述.
- 对用于心脏保护的天然产品进行临床前和临床研究的分析.
- 根据化学结构和作用机制对天然产品进行分类.
主要成果:
- 天然产品针对的经典机制,如炎症,氧化应激和纤维化.
- 新兴的机制包括心脏代谢调节和组织蛋白修饰.
- 自然产品调节新的途径,如调节细胞死亡和ncRNA级联.
结论:
- 天然产品显示出对心肌梗塞的多方面的治疗潜力.
- 对新型目标和化学结构进行进一步的研究是有必要的.
- 天然产品可以为MI管理提供有前途的补充或替代疗法.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
524
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
524
Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
Myocarditis III: Medical Management
20
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
20
Antianginal Drugs: Nitrates and β-Blockers
769
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
769
Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39
Angina IV: Management
31
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
31


